David Mayer

4.7k total citations · 1 hit paper
96 papers, 3.1k citations indexed

About

David Mayer is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, David Mayer has authored 96 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 32 papers in Hepatology and 14 papers in Transplantation. Recurrent topics in David Mayer's work include Organ Transplantation Techniques and Outcomes (41 papers), Liver Disease and Transplantation (28 papers) and Renal Transplantation Outcomes and Treatments (13 papers). David Mayer is often cited by papers focused on Organ Transplantation Techniques and Outcomes (41 papers), Liver Disease and Transplantation (28 papers) and Renal Transplantation Outcomes and Treatments (13 papers). David Mayer collaborates with scholars based in United Kingdom, United States and Germany. David Mayer's co-authors include John Buckels, Darius F. Mirza, Bridget Gunson, Paul McMaster, Simon R. Bramhall, Bernard Fried, Jacques Pirenne, Simon Olliff, Mehmet Ali Yerdel and Déirdre Kelly and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Mayer

90 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study

2023 75 citations Neil Krishan Aggarwal, Kyle C. Molina et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by David Mayer

Since Specialization

Citations

This map shows the geographic impact of David Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mayer more than expected).

Fields of papers citing papers by David Mayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mayer. The network helps show where David Mayer may publish in the future.

Co-authorship network of co-authors of David Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of David Mayer. A scholar is included among the top collaborators of David Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mayer. David Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study 2024 ·The Lancet Regional Health - Americas ·Neil R. Aggarwal, Laurel Beaty, Tellen D. Bennett, (unknown), (unknown), David Mayer, Kyle C. Molina, (unknown), Douglas B. Richardson, Seth Russell, (unknown), Brandon Webb, Matthew K. Wynia, Mengli Xiao, Nichole E. Carlson, Adit A. Ginde	3
2	Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5 2023 ·International Journal of Infectious Diseases ·Kyle C. Molina, (unknown), Laurel Beaty, Tellen D. Bennett, Nichole E. Carlson, David Mayer, (unknown), Seth Russell, Matthew K. Wynia, Neil R. Aggarwal, Adit A. Ginde	7
3	Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study breakdown → 2023 ·The Lancet Infectious Diseases ·Neil Krishan Aggarwal, Kyle C. Molina, Laurel Beaty, Tellen D. Bennett, Nichole E. Carlson, David Mayer, (unknown), Seth Russell, Matthew K. Wynia, Adit A. Ginde	75
4	Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients 2022 ·The Journal of Infectious Diseases ·Neil R. Aggarwal, Laurel Beaty, Tellen D. Bennett, Nichole E. Carlson, (unknown), Bethany M. Kwan, David Mayer, Toan C. Ong, Seth Russell, (unknown), Adane F. Wogu, Matthew K. Wynia, Richard D. Zane, Adit A. Ginde	36
5	ReviewR: a light-weight and extensible tool for manual review of clinical records 2022 ·JAMIA Open ·David Mayer, Luke V. Rasmussen, Christopher Roark, Michael G. Kahn, Lisa M. Schilling, Laura K. Wiley	3
6	COVID-19 Surveillance in the Biobank at the Colorado Center for Personalized Medicine: Observational Study 2022 ·JMIR Public Health and Surveillance ·Randi K. Johnson, (unknown), David Mayer, Jonathan Shortt, David Kao, Kathleen C. Barnes, Jan T. Lowery, Christopher R. Gignoux	3
7	Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase 2022 ·International Journal of Infectious Diseases ·Neil R. Aggarwal, Laurel Beaty, Tellen D. Bennett, Nichole E. Carlson, David Mayer, Kyle C. Molina, (unknown), Seth Russell, Matthew K. Wynia, Adit A. Ginde	17
8	A CLINICAL CASE OF SYSTEMIC AL-AMYLOIDOSIS WITH PECULIAR DISEASE PRESENTATION 2017 ·Nephrology (Saint-Petersburg) ·С. А. Болдуева, (unknown), (unknown), (unknown), David Mayer, Vladimir Dobronravov	0
9	Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience 2012 ·HPB ·Narendra Battula, Dimitrios Tsapralis, Arjun Takhar, C. Coldham, David Mayer, John Isaac, Paolo Muiesan, Robert P. Sutcliffe, Ravi Marudanayagam, Darius F. Mirza, Simon R. Bramhall	26
10	Uncontrolled organ donation following prehospital cardiac arrest: a potential solution to the shortage of organ donors in the United Kingdom? 2011 ·Transplant International ·Keith Roberts, Simon R. Bramhall, David Mayer, Paolo Muiesan	20
11	Liver tumours in patients with Abernethy malformation 2011 ·ANZ Journal of Surgery ·Vanessa Banz, Simon Olliff, Philippe Tanière, David Mayer, (unknown)	15
12	Hepatic venous outflow obstruction in paediatric liver transplantation 2010 ·Pediatric Surgery International ·Krishna Kumar Govindarajan, Khalid Sharif, David Mayer, Darius F. Mirza, Katharine Foster, Déirdre Kelly, A.J.W. Millar	26
13	Liver retransplantation in adults: a single-centre, 25-year experience 2010 ·HPB ·Ravi Marudanayagam, (unknown), Bynvant Sandhu, Bridget Gunson, Darius F. Mirza, David Mayer, John Buckels, Simon R. Bramhall	78
14	Pulmonary thromboembolism in liver transplantation: a retrospective review of the first 25 years 2010 ·Transplant International ·Thomas Cherian, K.W. Chiu, Bridget Gunson, Simon R. Bramhall, David Mayer, Darius F. Mirza, John Buckels	24
15	Renal Function Recovery in Children Undergoing Combined Liver Kidney Transplants 2009 ·Transplantation ·M. Thamara P. R. Perera, Patrick McKiernan, Khalid Sharif, David V. Milford, Carla Lloyd, David Mayer, Déirdre Kelly, Darius F. Mirza	15
16	Aetiology and outcome of acute liver failure 2009 ·HPB ·Ravi Marudanayagam, (unknown), Bridget Gunson, Darius F. Mirza, David Mayer, John Buckels, Simon R. Bramhall	51
17	Outcomes after identical and compatible orthotopic liver transplantation for fulminant hepatic failure: a single center experience in UK 2007 ·Transplant International ·(unknown), (unknown), (unknown), Bridget Gunson, Vijayaragavan Muralidharan, Stephen J. Wigmore, David Mayer, Darius F. Mirza, John Buckels, Simon R. Bramhall	7
18	A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors1 2004 ·Transplantation ·Koray Tekin, Charles Imber, Mesut Atlı, Bridget Gunson, Simon R. Bramhall, David Mayer, John Buckels, Paul McMaster, Darius F. Mirza	59
19	Generalised Mitochondrial Cytopathy Is an Absolute Contraindication to Orthotopic Liver Transplant in Childhood 1998 ·Journal of Pediatric Gastroenterology and Nutrition ·Mike Thomson, Patrick McKiernan, John Buckels, David Mayer, Déirdre Kelly	0
20	POSTOPERATIVE GLUCOSE METABOLISM IN LIVER TRANSPLANT RECIPIENTS 1994 ·Transplantation ·Andrew J. Krentz, Jan Dmitrewski, David Mayer, Paul McMaster, John Buckels, B. Dousset, Robert Cramb, Janet M. Smith, M. Nattrass	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact